Engineering the Next Generation of Biomaterials for Regenerative Medicine, Drug Delivery and Disease Modeling
Harnessing the power of bioactive ions to heal, regenerate, and deliver precision therapies.
Delivering transcription factors to reprogram cells and reverse osteoarthritic degeneration.
Developing expandable bandage that conforms to irregular wounds and rapidly stops bleeding.
Reprogramming mitochondria to restore cellular energy and function.
Bioprinting 3D glioblastoma models to recapitulate tumor–vasculature interactions for studying invasion, resistance, and treatment response.
Targeting epithelial–mesenchymal transition (EMT) using anti-angiogenic and anti-metastatic nanotherapeutics to inhibit tumor progression.
Reprogramming macrophage polarization from M1 to M2 phenotype to promote tissue repair and regeneration.
Developing injectable, biomaterial-based hemostats with controlled drug release to rapidly stop postpartum hemorrhage and improve maternal outcomes.
Designing pro-angiogenic biomaterials to stimulate rapid and functional vascularization of engineered tissue scaffolds.
Developed osteogenically active bioink for 3D printing irregular bone defects.
Engineering electronic skin with integrated sensors for real-time monitoring in soft robotics, prosthetics, and wearables.
Engineering nanomaterials to restore mitochondrial function and reprogram cellular bioenergetics for treating mitochondrial disorders.
Engineering the Next Generation of Biomaterials for Regenerative Medicine, Drug Delivery and Disease Modeling
Department of Biomedical Engineering
3044 Emerging Technology Building
101 Bizzell St
College Station, TX 77843-3120 (USA)
Engineering the Next Generation of Biomaterials for Regenerative Medicine, Drug Delivery and Disease Modeling
Department of Biomedical Engineering
3044 Emerging Technology Building
101 Bizzell St
College Station, TX 77843-3120 (USA)